Honeywell has divested its legacy Bendix asbestos liabilities to Delticus, streamlining its financial obligations and enhancing annual cash flow.
Information on the Target
Honeywell has successfully divested its legacy Bendix asbestos liabilities, including certain non-Bendix asbestos liabilities, to Delticus, a reputable corporate liability acquisition platform. This strategic move is pivotal as it signifies Honeywell's commitment to managing its financial obligations effectively while focusing on core business operations.
The divestiture involved the transfer of approximately $1.68 billion in cash and specific insurance assets linked to these liabilities to Delticus. As part of the deal, Delticus assumes full administrative responsibility for addressing all current and future asbestos-related claims, marking a significant step for Honeywell in its financial strategy.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target's Specific Country
The landscape for corporate liability acquisition firms in the United States is characterized by a growing focus on managing legacy liabilities efficiently. Companies are incre
Similar Deals
Tractors and Farm Equipment Limited → AGCO Corporation
2025
Booz Allen Hamilton → Shield AI
2025
Industrial Inspection & Analysis® (IIA) → Tribologik® Laboratories and Predictive Maintenance Corporation (PMC)
2024
Cibes Lift Group → Area Access Inc
2024
Delticus
invested in
Honeywell
in 2025
in a Corporate VC deal
Disclosed details
Transaction Size: $1,680M